☰

Gregoire Ruffenach - Publications

Affiliations: 
University of California, Los Angeles, Los Angeles, CA 
Area:
lung diseases
Tree Info Grants Similar researchers PubMed Report error

38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Ruffenach G, Medzikovic L, Sun W, Hong J, Eghbali M. Functions of RNA-Binding Proteins in Cardiovascular Disease. Cells. 12. PMID 38132114 DOI: 10.3390/cells12242794  0.478
2023 Medzikovic L, Aryan L, Ruffenach G, Li M, Savalli N, Sun W, Sarji S, Hong J, Sharma S, Olcese R, Fishbein G, Eghbali M. Myocardial fibrosis and calcification are attenuated by microRNA-129-5p targeting Asporin and Sox9 in cardiac fibroblasts. Jci Insight. 8. PMID 37154157 DOI: 10.1172/jci.insight.168655  0.463
2022 Hong J, Wong B, Huynh C, Tang B, Ruffenach G, Li M, Umar S, Yang X, Eghbali M. Tm4sf1-marked Endothelial Subpopulation Is Dysregulated in Pulmonary Arterial Hypertension. American Journal of Respiratory Cell and Molecular Biology. PMID 36252184 DOI: 10.1165/rcmb.2022-0020OC  0.726
2022 Ruffenach G, Medzikovic L, Aryan L, Li M, Eghbali M. HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial Hypertension. Circulation. 101161CIRCULATIONAHA. PMID 35993245 DOI: 10.1161/CIRCULATIONAHA.122.059591  0.55
2022 Cunningham CM, Li M, Ruffenach G, Doshi M, Aryan L, Hong J, Park J, Hrncir H, Medzikovic L, Umar S, Arnold AP, Eghbali M. Y-Chromosome Gene, , Protects Against Pulmonary Hypertension by Reducing Proinflammatory Chemokines. American Journal of Respiratory and Critical Care Medicine. PMID 35504005 DOI: 10.1164/rccm.202110-2309OC  0.768
2022 Jayawardena E, Medzikovic L, Ruffenach G, Eghbali M. Role of miRNA-1 and miRNA-21 in Acute Myocardial Ischemia-Reperfusion Injury and Their Potential as Therapeutic Strategy. International Journal of Molecular Sciences. 23. PMID 35163436 DOI: 10.3390/ijms23031512  0.444
2020 Ruffenach G, Hong J, Vaillancourt M, Medzikovic L, Eghbali M. Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights. Respiratory Research. 21: 303. PMID 33208169 DOI: 10.1186/s12931-020-01570-2  0.575
2020 Hong J, Arneson D, Umar S, Ruffenach G, Cunningham CM, Ahn IS, Diamante G, Bhetraratana M, Park JF, Said E, Huynh C, Le T, Medzikovic L, Humbert M, Soubrier F, et al. Single-cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning. American Journal of Respiratory and Critical Care Medicine. PMID 33021809 DOI: 10.1164/rccm.202006-2169OC  0.748
2020 Medzikovic L, Cunningham CM, Li M, Amjedi M, Hong J, Ruffenach G, Eghbali M. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19. Journal of Molecular and Cellular Cardiology. PMID 32835666 DOI: 10.1016/J.Yjmcc.2020.08.007  0.524
2020 Ruffenach G, O'Connor E, Vaillancourt M, Hong J, Cao N, Sarji S, Moazeni S, Papesh J, Grijalva V, Cunningham CM, Shu L, Chattopadhyay A, Tiwari S, Mercier O, Perros F, et al. Oral 15-Hydroxyeicosatetraenoic Acid Induces Pulmonary Hypertension in Mice by Triggering T Cell-Dependent Endothelial Cell Apoptosis. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA12014. PMID 32713273 DOI: 10.1161/Hypertensionaha.120.14697  0.775
2020 Aryan L, Younessi D, Zargari M, Banerjee S, Agopian J, Rahman S, Borna R, Ruffenach G, Umar S, Eghbali M. The Role of Estrogen Receptors in Cardiovascular Disease. International Journal of Molecular Sciences. 21. PMID 32560398 DOI: 10.3390/Ijms21124314  0.725
2020 Umar S, Ruffenach G, Moazeni S, Vaillancourt M, Hong J, Cunningham C, Cao N, Navab S, Sarji S, Li M, Lee L, Fishbein G, Ardehali A, Navab M, Reddy ST, et al. Involvement of Low-Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension. Journal of the American Heart Association. 9: e012063. PMID 31914876 DOI: 10.1161/Jaha.119.012063  0.742
2020 Ruffenach G, Bonnet S, Rousseaux S, Khochbin S, Provencher S, Perros F. Identity crisis in pulmonary arterial hypertension. Pulmonary Circulation. 8: 2045893217746054. PMID 29206084 DOI: 10.1177/2045893217746054  0.438
2020 Cunningham CM, Umar S, Doshi M, Li M, Ruffenach G, Hrncir H, Arnold AP, Eghbali M. Y‐Chromosome Gene, Uty, Protects Against Pulmonary Hypertension by Reducing Lung Pro‐Inflammatory Cytokines The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.02378  0.755
2019 Vaillancourt M, Chia P, Medzikovic L, Cao N, Ruffenach G, Younessi D, Umar S. Experimental Pulmonary Hypertension Is Associated With Neuroinflammation in the Spinal Cord. Frontiers in Physiology. 10: 1186. PMID 31616310 DOI: 10.3389/Fphys.2019.01186  0.708
2019 Ruffenach G, Umar S, Vaillancourt M, Hong J, Cao N, Sarji S, Moazeni S, Cunningham CM, Ardehali A, Reddy ST, Saggar R, Fishbein G, Eghbali M. Histological hallmarks and role of Slug/PIP axis in pulmonary hypertension secondary to pulmonary fibrosis. Embo Molecular Medicine. e10061. PMID 31468711 DOI: 10.15252/Emmm.201810061  0.758
2019 Duhachek-Muggy S, Bhat K, Medina P, Cheng F, He L, Alli C, Saki M, Sree Muthukrishnan SD, Ruffenach G, Eghbali M, Vlashi E, Pajonk F. Radiation Mitigation of the Intestinal Acute Radiation Injury in Mice by 1-[(4-Nitrophenyl)Sulfonyl]-4-Phenylpiperazine. Stem Cells Translational Medicine. PMID 31464098 DOI: 10.1002/Sctm.19-0136  0.479
2019 Ruffenach G, Vaillancourt M, Hong J, Cao N, Cunningham C, Saggar R, Reddy S, Umar S, Fishbein G, Eghbali M. Abstract 494: Role of Slug / PIP Axis in Pulmonary Hypertension Secondary to Pulmonary Fibrosis Circulation Research. 125. DOI: 10.1161/Res.125.Suppl_1.494  0.774
2019 Ruffenach G, O'Connor E, Vaillancourt M, Sarji S, Cao N, Aryan L, Cunningham C, Grijalva V, Umar S, Reddy S, Eghbali M, Moazeni D. Abstract 226: Apoai Mimetic Peptide 6f Prevent Pulmonary Hypertension Induced by Oxidized Lipids Circulation Research. 125. DOI: 10.1161/Res.125.Suppl_1.226  0.743
2019 Oconnor EI, Ruffenach G, Grijalva V, Meriwether D, Papesh J, Dorreh N, Dorfman A, Eghbali M, Reddy S. Abstract 225: Evaluating Pro-Inflammatory and Pro-Resolving Lipid Modulations in an Oral 15-HETE Model of Pulmonary Hypertension Circulation Research. 125. DOI: 10.1161/Res.125.Suppl_1.225  0.622
2018 F Tanguay V, Babin C, Giardetti G, Sohier-Poirier C, Ménard-Cholette V, Ranchoux B, Ruffenach G, Montani D, Bonnet S, Provencher S. Enhanced Pulmonary Artery Radiodensity in Pulmonary Arterial Hypertension: A Sign of Early Calcification? American Journal of Respiratory and Critical Care Medicine. PMID 30571924 DOI: 10.1164/Rccm.201806-1027Le  0.513
2018 Iorga A, Umar S, Ruffenach G, Aryan L, Li J, Sharma S, Motayagheni N, Nadadur RD, Bopassa JC, Eghbali M. Estrogen rescues heart failure through estrogen receptor Beta activation. Biology of Sex Differences. 9: 48. PMID 30376877 DOI: 10.1186/S13293-018-0206-6  0.684
2018 Ruffenach G, O’Connor EI, Vaillancourt M, Sarji S, Cao N, Aryan L, Cunningham C, Grijalva V, Umar S, Reddy ST, Eghbali M. Abstract 250: Pulmonary Hypertension Induced by 15-HETE is Reverse by Apoai Mimetic Peptide 6f Administration Circulation Research. 123. DOI: 10.1161/Res.123.Suppl_1.250  0.742
2017 Vaillancourt M, Chia P, Sarji S, Nguyen J, Hoftman N, Ruffenach G, Eghbali M, Mahajan A, Umar S. Autonomic nervous system involvement in pulmonary arterial hypertension. Respiratory Research. 18: 201. PMID 29202826 DOI: 10.1186/S12931-017-0679-6  0.784
2017 Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biology of Sex Differences. 8: 33. PMID 29065927 DOI: 10.1186/S13293-017-0152-8  0.698
2017 Vaidya B, Pangallo M, Ruffenach G, Cunningham CM, Perron JC, Kolluru S, Eghbali M, Gupta V.. Advances in treatment of pulmonary arterial hypertension: patent review. Expert Opin Ther Pat.. 11: 1-12. PMID 28355094 DOI: 10.1080/13543776.2017.1313232.  0.34
2017 Vaidya B, Pangallo M, Ruffenach G, Cunningham CM, Perron JC, Kolluru S, Eghbali M, Gupta V. Advances in treatment of pulmonary arterial hypertension: patent review. Expert Opinion On Therapeutic Patents. PMID 28355094 DOI: 10.1080/13543776.2017.1313232  0.622
2017 Umar S, Partow-Navid R, Ruffenach G, Iorga A, Moazeni S, Eghbali M. Severe pulmonary hypertension in aging female apolipoprotein E-deficient mice is rescued by estrogen replacement therapy. Biology of Sex Differences. 8: 9. PMID 28344760 DOI: 10.1186/S13293-017-0129-7  0.726
2016 Li J, Ruffenach G, Kararigas G, Cunningham CM, Motayagheni N, Barakai N, Umar S, Regitz-Zagrosek V, Eghbali M. Intralipid protects the heart in late pregnancy against ischemia/reperfusion injury via Caveolin2/STAT3/GSK-3β pathway. Journal of Molecular and Cellular Cardiology. PMID 27847332 DOI: 10.1016/J.Yjmcc.2016.11.006  0.67
2016 Sharma S, Ruffenach G, Umar S, Motayagheni N, Reddy ST, Eghbali M. Role of oxidized lipids in pulmonary arterial hypertension. Pulmonary Circulation. 6: 261-73. PMID 27683603 DOI: 10.1086/687293  0.783
2016 Anwar A, Ruffenach G, Mahajan A, Eghbali M, Umar S. Novel biomarkers for pulmonary arterial hypertension. Respiratory Research. 17: 88. PMID 27439993 DOI: 10.1186/S12931-016-0396-6  0.771
2016 Ruffenach G, Chabot S, Tanguay VF, Courboulin A, Boucherat O, Potus F, Meloche J, Pflieger A, Breuils-Bonnet S, Nadeau V, Paradis R, Tremblay E, Girerd B, Hautefort A, Montani D, et al. Role for RUNX2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. PMID 27149112 DOI: 10.1164/Rccm.201512-2380Oc  0.475
2016 Antigny F, Hautefort A, Meloche J, Belacel-Ouari M, Manoury B, Rucker-Martin C, Péchoux C, Potus F, Nadeau V, Tremblay E, Ruffenach G, Bourgeois A, Dorfmüller P, Breuils-Bonnet S, Fadel E, et al. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension. Circulation. 133: 1371-85. PMID 26912814 DOI: 10.1161/Circulationaha.115.020951  0.505
2016 Antigny F, Hautefort A, Meloche J, Belacel-Ouari M, Manoury B, Rucker-Martin C, Péchoux C, Potus F, Nadeau V, Tremblay E, Ruffenach G, Bourgeois A, Dorfmüller P, Breuils-Bonnet S, Fadel E, et al. Potassium-Channel Subfamily K-Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension Circulation. DOI: 10.1161/CIRCULATIONAHA.115.020951  0.331
2015 Meloche J, Potus F, Vaillancourt M, Bourgeois A, Johnson IH, Deschamps L, Chabot S, Ruffenach GN, Henry S, Breuils-Bonnet S, Tremblay È, Nadeau V, Lambert CM, Paradis R, Provencher S, et al. Bromodomain Containing Protein-4: The Epigenetic Origin of Pulmonary Arterial Hypertension. Circulation Research. PMID 26224795 DOI: 10.1161/Circresaha.115.307004  0.466
2015 Potus F, Ruffenach G, Dahou A, Thebault C, Breuils-Bonnet S, Tremblay È, Nadeau V, Paradis R, Graydon C, Wong R, Johnson I, Paulin R, Lajoie AC, Perron J, Charbonneau E, et al. Downregulation of miR-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension. Circulation. PMID 26162916 DOI: 10.1161/Circulationaha.115.016382  0.463
2015 Vaillancourt M, Ruffenach G, Meloche J, Bonnet S. Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension. The Canadian Journal of Cardiology. 31: 407-15. PMID 25630876 DOI: 10.1016/J.Cjca.2014.10.023  0.518
2014 Ruffenach G, Breuils-Bonnet S, Tremblay E, Provencher S, Bonnet S. IMPLICATION OF TRANSCRIPTIONAL FACTOR RUNX2 IN PULMONARY ARTERIAL HYPERTENSION Canadian Journal of Cardiology. 30: S124-S125. DOI: 10.1016/J.Cjca.2014.07.165  0.397
Show low-probability matches.